These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia. Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741 [TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome associated with olanzapine. Filice GA; McDougall BC; Ercan-Fang N; Billington CJ Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080 [TBL] [Abstract][Full Text] [Related]
5. [Neuroleptic malignant syndrome after treatment with olanzapine]. Emborg C Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome due to olanzapine. Hall KL; Taylor WH; Ware MR Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878 [TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy. Berry N; Pradhan S; Sagar R; Gupta SK Pharmacotherapy; 2003 Feb; 23(2):255-9. PubMed ID: 12587815 [TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic. Mujica R; Weiden P Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706 [No Abstract] [Full Text] [Related]
18. [Neuroleptic malignant syndrome in a patient treated with olanzapine]. Horni G; Meirik K; Lund MB Tidsskr Nor Laegeforen; 2003 Oct; 123(20):2867-9. PubMed ID: 14600711 [TBL] [Abstract][Full Text] [Related]
19. [Neuroleptic malignant syndrome: case report with recurrence associated with the use of olanzapine]. Hanel RA; Sandmann MC; Kranich M; De Bittencourt PR Arq Neuropsiquiatr; 1998 Dec; 56(4):833-7. PubMed ID: 10029891 [TBL] [Abstract][Full Text] [Related]